Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 15,000 shares at $124.00 ($1.9M) on 2020-06-19, disclosed to the SEC on 2020-06-23.
Seasonal sale ($1.9M) by EVP, Chief Commercial Officer — this insider has traded BMRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |